Pharyngitis Treatment Market: Global Industry Analysis and Forecast (2022-2027) by Source of Infection, Drug Class, Distribution Channel, and Region

Pharyngitis Treatment Market size was valued at US$ 2.1 Bn. in 2021 and the total Pharyngitis Treatment revenue is expected to grow at 4.4% through 2022 to 2027, reaching nearly US$ 2.72 Bn.

Pharyngitis Treatment Market Overview:

Pharyngitis is a clinical disorder that involves inflammation in the pharynx i.e. the back of the throat. A painful throat is referred to as pharyngitis. Itching and trouble swallowing are other symptoms of pharyngitis. Pharyngitis is caused by a variety of bacterial and viral agents, the most common of which are measles, adenovirus, high cough, and streptococcus. A viral infection, e.g. the common cold, influenza, or mononucleosis, is the most prevalent cause of pharyngitis. Pharyngitis Treatment Market To know about the Research Methodology:- Request Free Sample Report In 2020, there were over 2.8 million people who went to the emergency room with pharyngitis, with 1.1 million of them being children under the age of 16. Pharyngitis is most common in kids under the age of five. Adults can have the condition as well, albeit at a slower pace. Pharyngitis incidences are quite high over the world, particularly in nations when antibiotics are widely prescribed. According to recent research, around 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can lead to a serious non-suppurative reaction. Even though acute pharyngitis is one of the most common diseases among school-going children, GAS pharyngitis is uncommon. GAS pharyngitis and non-streptococcal pharyngitis have similar clinical appearances, making it difficult for doctors to distinguish between them without laboratory analysis. In this report, the Pharyngitis Treatment market's growth reasons, as well as the market's many segments (Source of Infection, Drug Class, Distribution Channel, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Pharyngitis Treatment market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Pharyngitis Treatment market situation.

Pharyngitis Treatment Market Dynamics:

The development of the COVID-19 pandemic has altered how medical treatment is delivered across the world. The Pharyngitis Treatment industry has been badly impacted by the COVID-19 pandemic, which has resulted in adverse changes in rules and standards, the closure of production facilities owing to lockdowns, and supply chain disruptions. Furthermore, owing to lockdowns, the distribution of Pharyngitis Treatment products to end-users has been restricted due to limited functioning in most businesses, insufficient financing for studies and research establishments, and difficulty in delivering vital services. The Human Genome Project and breakthroughs in biochemical and clinical technology have led to the creation of a plethora of tests and technologies useful for the diagnosis and management of respiratory infections. These new technologies, which are based on genomic approaches, aid in the discovery of novel viruses. They also allow for improved surveillance and quick detection of infectious illnesses, which presents a business potential. Most diagnostic businesses have a significant difficulty in commercializing their tests: convincing Medicaid and private insurance providers to cover for them. This is critical not just for assisting clinicians in their choice in the practice of evidence-approved medicine, but also for obtaining legislative clearances and payments for the tests. In recent years, regulatory changes for virus tests have gotten increasingly strict in order to verify that they are effective at identifying all forms of respiratory viruses.

Pharyngitis Treatment Market Segment Analysis:

By Source of Infection, the viral segment is expected to grow at a CAGR of 3.8% in the previously mentioned forecast period. This growth can be attributed mainly to the coronavirus crisis that happened in 2020. The World Health Organization (WHO) advises countries to maintain routine viral disease surveillance, specimens from surveillance sites for viral diseases and coronavirus where facilities are allocated, and report experimental and epidemiological data to established regional and international platforms in a reasonable timeframe. Increased viral diagnosis is projected to have a positive impact on the segment, as more patients may seek antiviral medications after being infected. Overall, the COVID-19 outbreak is expected to benefit the segment under consideration. Flu, AIDS, and Ebola virus public awareness campaigns are also a crucial component in raising public knowledge and, as a result, affecting segment growth. The virology business is continually responding to the medical sector's preventative and curative demands. Several disorders, on the other hand, continue to necessitate fresh solution R&D, propelling the segment growth forward. Virology applications are used in a variety of therapies and diagnostic procedures, which is supporting the segment growth.

Pharyngitis Treatment Market Regional Insights:

On the basis of high healthcare spending, the greatest health awareness among people, and massive investments in research and development projects, the North American region is expected to earn the biggest share at the end of the projection period. According to another WHO estimate, North America's per capita healthcare spending in 2020 was US$ 4.1 trillion. Furthermore, the presence of large pharmaceutical companies, as well as massive investment in drug development and utilization, is expected to support market growth in the region. At the end of the projection period, Europe is expected to continue its position as the world's second-largest market for respiratory diseases, pharyngitis in particular. Europe is expected to have the greatest CAGR of 5.6%, thanks to improved healthcare infrastructure, simplified diagnostics, and the lowered costs of viral illness diagnostic tests. Pharyngitis Treatment Market 1 The objective of the report is to present a comprehensive analysis of the Pharyngitis Treatment market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Pharyngitis Treatment market dynamics, structure by analyzing the market segments and projecting the Pharyngitis Treatment market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Pharyngitis Treatment market make the report investor’s guide.

Pharyngitis Treatment Market Scope: Inquire before buying

Global Pharyngitis Treatment Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 2.1 Bn.
Forecast Period 2021 to 2027 CAGR: 4.4 % Market Size in 2027: US $ 2.72 Bn.
Segments Covered: by Source of Infection • Viral • Bacterial
by Drug Class • Beta Lactams • Macrolides • Cephalosporins • Fluoroquinolones • Tetracycline • Other
by Distribution Channel • Hospital Pharmacies • Retail Pharmacies and Drug Stores • Online Pharmacies

Pharyngitis Treatment Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Pharyngitis Treatment Market Key Players

Genentech Inc • Adamas Pharmaceutical Inc • PLIVA HRVATSKA d.o.o • Pfizer Inc • Valeant Pharmaceuticals International, Inc • Mylan N.V • GSK group of companies • Teva Pharmaceutical Industries Ltd • AbbVie Inc • Viatris Inc. (Mylan) • GlaxoSmithKline plc • Abbott Laboratories • AbbVie Inc • Amgen Inc • Sanofi-aventis Groupe • Purdue Pharma L.P

FAQs:

1. Which is the potential market for Pharyngitis Treatment in terms of the region? Ans. the North American region is expected to earn the biggest share at the end of the projection period. 2. What are the opportunities for new market entrants? Ans. The Human Genome Project and breakthroughs in biochemical and clinical technology have led to the creation of a plethora of tests and technologies 3. What is expected to drive the growth of the Pharyngitis Treatment market in the forecast period? Ans. The development of the COVID-19 pandemic has altered how medical treatment is delivered across the world. 4. What is the projected market size & growth rate of the Pharyngitis Treatment Market? Ans. Pharyngitis Treatment Market size was valued at US$ 2.1 Bn. in 2021 and the total Pharyngitis Treatment revenue is expected to grow at 4.4% through 2022 to 2027, reaching nearly US$ 2.72 Bn. 5. What segments are covered in the Pharyngitis Treatment Market report? Ans. The segments covered are Source of Infection, Drug Class, Distribution Channel, and Region.
1. Global Pharyngitis Treatment Market: Research Methodology 2. Global Pharyngitis Treatment Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Pharyngitis Treatment Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Pharyngitis Treatment Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Pharyngitis Treatment Market Segmentation 4.1 Global Pharyngitis Treatment Market, by Source of Infection (2022-2027) • Viral • Bacterial 4.2 Global Pharyngitis Treatment Market, by Drug Class (2022-2027) • Beta Lactams • Macrolides • Cephalosporins • Fluoroquinolones • Tetracycline • Other 4.3 Global Pharyngitis Treatment Market, by Distribution Channel (2022-2027) • Hospital Pharmacies • Retail Pharmacies and Drug Stores • Online Pharmacies 5. North America Pharyngitis Treatment Market(2022-2027) 5.1 Global Pharyngitis Treatment Market, by Source of Infection (2022-2027) • Viral • Bacterial 5.2 Global Pharyngitis Treatment Market, by Drug Class (2022-2027) • Beta Lactams • Macrolides • Cephalosporins • Fluoroquinolones • Tetracycline • Other 5.3 Global Pharyngitis Treatment Market, by Distribution Channel (2022-2027) • Hospital Pharmacies • Retail Pharmacies and Drug Stores • Online Pharmacies 5.4 North America Pharyngitis Treatment Market, by Country (2022-2027) • United States • Canada • Mexico 6. Asia Pacific Pharyngitis Treatment Market (2022-2027) 6.1. Asia Pacific Pharyngitis Treatment Market, by Source of Infection (2022-2027) 6.2. Asia Pacific Pharyngitis Treatment Market, by Drug Class (2022-2027) 6.2. Asia Pacific Pharyngitis Treatment Market, by Distribution Channel (2022-2027) 6.2. Asia Pacific Pharyngitis Treatment Market, by Country (2022-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Pharyngitis Treatment Market (2022-2027) 7.1 Middle East and Africa Pharyngitis Treatment Market, by Source of Infection (2022-2027) 7.2. Middle East and Africa Pharyngitis Treatment Market, by Drug Class (2022-2027) 7.2. Middle East and Africa Pharyngitis Treatment Market, by Distribution Channel (2022-2027) 7.4. Middle East and Africa Pharyngitis Treatment Market, by Country (2022-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Pharyngitis Treatment Market (2022-2027) 8.1. Latin America Pharyngitis Treatment Market, by Source of Infection (2022-2027) 8.2. Latin America Pharyngitis Treatment Market, by Drug Class (2022-2027) 8.2. Latin America Pharyngitis Treatment Market, by Distribution Channel (2022-2027) 8.4 Latin America Pharyngitis Treatment Market, by Country (2022-2027) • Brazil • Argentina • Rest Of Latin America 9. European Pharyngitis Treatment Market (2022-2027) 9.1. European Pharyngitis Treatment Market, by Source of Infection (2022-2027) 9.2. European Pharyngitis Treatment Market, by Drug Class (2022-2027) 9.3. European Pharyngitis Treatment Market, by Distribution Channel (2022-2027) 9.4. European Pharyngitis Treatment Market, by Country (2022-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1 Genentech Inc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Adamas Pharmaceutical Inc 10.3 PLIVA HRVATSKA d.o.o 10.4 Pfizer Inc 10.5 Valeant Pharmaceuticals International, Inc 10.6 Mylan N.V 10.7 GSK group of companies 10.8 Teva Pharmaceutical Industries Ltd 10.9 AbbVie Inc 10.10 Viatris Inc. (Mylan) 10.11 GlaxoSmithKline plc 10.12 Abbott Laboratories 10.13 AbbVie Inc 10.14 Amgen Inc 10.15 Sanofi-aventis Groupe 10.16 Purdue Pharma L.P

About This Report

Report ID 106231
Category Healthcare
Published Date Jun 2021
Updated Date Feb 2022
Contact Us